Dougherty & Co Starts MAKO Surgical (MAKO) at Buy; Valuation Rich...But For A Reason
Tweet
Share
E-mailGet Alerts MAKO Hot Sheet
Price: $10.12 +3.79%
Rating Summary:
1 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Dougherty & Co initiates coverage on MAKO Surgical (NASDAQ: MAKO) with a Buy. PT $35.00.
Analyst, Junaid Husain, said, "Our recommendation is predicated on the following: 1) Robotics & MAKOplasty: A Minimally-Invasive Approach to Orthopedic Surgery. We’re fans of the RIO System and RESTORIS implants which are used in MAKOplasty, a minimally-invasive orthopedic surgical procedure; 2) MAKOplasty PKA: Better Clinical & Economic Outcomes - Attractive Market; 3) MAKOplasty THA: Still Early in the Rollout, But Could Be Meaningful...We See MAKOplasty As a Valuable Marketing Tool for Hospitals & Surgeons; and 4) Solid MAKOplasty Growth Should Drive Robust Sales and Breakeven by CY13."
For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.
Shares of MAKO Surgical closed at $25.46 yesterday.
Analyst, Junaid Husain, said, "Our recommendation is predicated on the following: 1) Robotics & MAKOplasty: A Minimally-Invasive Approach to Orthopedic Surgery. We’re fans of the RIO System and RESTORIS implants which are used in MAKOplasty, a minimally-invasive orthopedic surgical procedure; 2) MAKOplasty PKA: Better Clinical & Economic Outcomes - Attractive Market; 3) MAKOplasty THA: Still Early in the Rollout, But Could Be Meaningful...We See MAKOplasty As a Valuable Marketing Tool for Hospitals & Surgeons; and 4) Solid MAKOplasty Growth Should Drive Robust Sales and Breakeven by CY13."
For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.
Shares of MAKO Surgical closed at $25.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
